Which closed-end funds own Viridian Therapeutics Inc?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $4M. Security type: common equity. Country: United States. CUSIP 92790C104 · ISIN US92790C1045 · ticker VRDN.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.29% | $3.2M | 173,120 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.14% | $827K | 45,005 sh | $573M | 3.7% discount | Jun 30, 2026 |
| BRW Saba Capital Income & Opportunities Fund | U.S. Equity | -0.01% | $-26.4K | -1,393 sh | $351M | 17.8% discount | Jul 31, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Viridian Therapeutics Inc | debt security | 3 |
Issuer-level search for “VRDN” → · Compare two funds’ portfolios →